Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,279 | Dovepress* | 3,938+ | 171 | 4,109 | |
| PubMed Central* | 341 | 137 | 478 | ||
| Totals | 4,279 | 308 | 4,587 | ||
| *Since 11 October 2022 | |||||
View citations on PubMed Central and Google Scholar